Understanding

Dear Stacey: Are There Costly Consequences to Co-Pay Accumulator Programs?

What is a co-pay accumulator, and how will it affect cancer patients access to treatment? Noted healthcare attorney Stacey Worthy discusses what patients need to know about the “double-dip” insurance deductible.

Published:

Mantle Cell Lymphoma News From ASH 2018: Treatment Research Updates

On-site in San Diego at the 2018 American Society of Hematology (ASH) annual meeting, Patient Power founder Andrew Schorr is joined by renowned expert Dr. Peter Martin to discuss highlights in mantle cell lymphoma treatment news.

Published:

ASH 2018 Daily Wrap: MPN News

On location in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

Clinical Trial MythBusters: What Is the Value of Diversity in Clinical Trials?

Is diversity, gender, age and ethnicity important in clinical trials? Mel Mann, a 20+ year CML survivor and a a highly respected leader in the field of clinical oncology weigh in.

Published:

Will I Feel Like a Guinea Pig? A Four-Time Clinical Trial Participant Shares Her Experience

A common question patients have when considering a clinical trial is “will I be a guinea pig?” Meet Reina Weiner, a four-time clinical trial participant, as she shares her experience navigating the trial process, patient consent, safety, risks, family issues and more.

Published:

Can Low Clinical Trial Participation Inhibit Cancer Research and Innovation?

Lazarex chairman Dana Dornsife says that there’s a “48 percent failure rate of clinical trials, and it's not because the drug didn't work.” Why do some medicines never make it to market? Watch now to find out.

Published:

Finding the Right Match: Advice for Patients Who Qualify for Multiple Clinical Trials

Which clinical trial is the best choice for you? Watch now to hear Dr. Mike Thompson and patient advocate Jim Omel discuss factors to consider when weighing your options and share tips for patients trying to prioritize different trials.

Published:

Step One in Trial Participation: How Can Patients Learn About New Trials?

Myeloma survivor Reina Weiner and Lazarex chairman Dana Dornsife discuss ways patients can learn about new clinical trial opportunities and share resources to help alleviate the financial burden.

Published:

Transparency in Clinical Trials: Data, Safety and Monitoring of Cancer Patients

Many patients wonder; how safe are clinical trials? How transparent is the data from clinical research? Tune in to hear Dr. Mike Thompson and Jim Omel discuss clinical trial care and how the efficacy of new cancer treatments is determined.

Published:

Showing 9 of 62 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on August 22, 2018